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Seminalplasmm (SPLN) is a 47-residue protein from bovine seminalplasma having broad-spectrum antibacterial activity. The protein has no 
hemolytic activity. SPLN interacts with lipid vesicles and its antibacterial activity appears to stem from its ability to permeabihze the bacterial plasma 
membrane. Analysis of SPLN’s primary structure, with respect to its relative hydrophobicity and hydrophihcity, revealed a segment, 
PKLLETFLSKWIG, more hydrophobic than the rest of the protein. A synthetic peptide correspondmg to this region had not only antibacterial 
activtty but also hemolytic properties. Analysis of the SPLN sequence based on hydrophobic moment plots has revealed a second segment, 
SLSRYAKLANRLA, which could be membrane active. A synthetic peptide corresponding to this region shows only antibacterial activity with 
no hemolytic activity. 
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1. INTRODUCTION 
Peptides possessing antimicrobial activity play an im- 
portant role in insect immunity [l]. contribute to host 
defense mechanisms in higher mammals [2], and also 
prevent infection in frogs, particularly on the skin sur- 
face [3]. Although some of these peptides, like cecropins 
and defensins, have significant potency, as well as a 
broad antimicrobial spectrum, antiviral and antifungal 
properties [1,4,5], they are relatively long, composed of 
- 37 residues. Also, defensins adopt highly folded 
structures with three disulphide bridges [6]. Hence, syn- 
thesis of these peptides in large quantities, as would be 
needed for use as a drug, would be difficult and expen- 
sive, and consequently their use as therapeutic agents is 
likely to be limited. The biological activity of these pep- 
tides results from their ability to form ion channels 
through membranes [7,8]. It would thus be pertinent to 
identify and examine the membrane activity of short 
segments of these peptides, particularly those which 
adopt amphiphilic a-helical conformations, as they 
would help to reveal the minimum requirement for bio- 
logical activity. Also, short peptides would be more 
amenable to synthesis, and consequently would be of 
use in therapeutic applications. 
meabilizing the bacterial plasma membrane [ 111. It also 
interacts with lipid vesicles, and its biological activity 
can be rationalized in terms of lipid-peptide interac- 
tions [ 121. With a view to delineate regions of the protein 
that might have features which would favour interac- 
tion with membranes, its primary structure was ana- 
lyzed with respect to its relative hydrophobicity and 
hydrophilicity. based on the method of Kyte and 
Doolittle [13]. A region comprising 13 amino acids, 
PKLLETFLSKWIG (SPF), was identified to be more 
hydrophobic than the rest of the protein [14]. A syn- 
thetic peptide corresponding to this region had not only 
antimicrobial activity but also lysed erythrocytes. In 
this paper we report the identification of another 13- 
residue segment, SLSRYAKLANRLA (SLS), in 
SPLN, based on hydrophobic moment analysis, having 
only antibacterial activity without hemolytic properties. 
2. EXPERIMENTAL 
Seminalplasmin (SPLN) is a 47-residue protein from 
bovine seminalplasma (Fig. 1) that has broad-spectrum 
antibacterial activity with no hemolytic properties 
[9,10]. The protein appears to exert its activity by per- 
Peptide synthesis was achieved on triethyleneglycoldimethyl- 
acrylate-crosshnked (1%) polystyrene resin using t-hoc chemistry and 
protocols essenttally as described earlier [15,16]. The peptide was pu- 
rified by fast-performance liquid chromatography (FPLC) and char- 
acterized by ammo acid analysis and sequencing on an Apphed Bio- 
systems 473A sequencer. 
The antibacterial activity of the peptide was determined by incubat- 
ing an inoculum of E coli W 160.37 (10’ CFUlml) m minimal A 
medium [17] for 6 h in the absence and presence of various concentra- 
tions of peptide. The value of A,,o for control cultures, which con- 
tamed no peptide, was taken as 100%. 
Correspondence address. R. Nagaraj, Centre for Cellular and Molecu- 
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Lipid vesicles with entrapped carboxyfluorescein (CF) were pre- 
pared as follows. A lipid film of dioleoylphosphatidyl choline (DOPC) 
(Avanti Polar Lipids) was dispersed m 5 mM 4-(2-hydroxyethyl)-l- 
piperazmeethane sulfonic acid (HEPES), pH 7.4, containing 50 mM 
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Fig. 1. Primary structure of bovine seminalplasmm. 
NaCl and 155 mM CF, and somcated to clartty. Llposomes were 
separated from non-encapsulated CF by gel-filtration on Sephndex 
G-75 (elution buffer, 5 mM HEPES. pH 7.4. 150 mM NaCl, 1 mM 
EDTA). The excitatron and emission monochromators were set at 493 
nm and 520 nm, respectrvely. Complete release of CF from hpid 
vesieies was obtained by addrtron of Triton X-150 (0.1% v/v) and the 
Auorescence value was taken as 155% release. Fluorescence was con- 
tmuously monitored afier addition of pepttde to hptd vesicles. 
3. RESULTS AND DISCUSSION 
SPLN adopts an a-helical conformation, particularly 
in hydrophobic environment. Recent reports indicate 
that peptide fragments of a helical protein or peptide 
show marked conformational preference for helix and 
nascent helix [l&20]. Hence, we analyzed the sequence 
of SPLN with the hydrophobicity and hydrophobic mo- 
ment plot according to the method of Eisenberg and 
Wesson for amphiphitic a-helices [Zl] with the use of an 
1 l-residue window. Apart from the sequence of SPF? 
which falls in the area of surface-seeking peptides in the 
hydrophobic moment vs. hydrophobicity plot, another 
sequence, SLSRYAKLANRLA (SLS), was also found 
to fall in this region. This sequence has a hydrophobic 
moment of 0.68 and average hydrophobicity of -0.19. 
This sequence has also been postulated as the calmod- 
ulin-binding d.omain in SPLN, based on a similar anal- 
ysis [22]. Hence. a peptide corresponding to this se- 
[PEPT~DE] @g/ml 
Fig. 2. Antimicrobial acttvity of SLS E. coli W160-37 was incubated 
with varymg concentratrons of peptide in minimal A medium (I ml) 
for 6 h. The absorbance at 600 nm was measured after 6 h and the 
value for control cultures whtch contamed no peptides was taken as 
100%. 
quence was synthesized and its antimicrobial properties 
determined. 
The inhibition of growth of E. coii in the presence of 
varying concentrations of peptide SLS is shown in Fig. 
2. The data indicate a minimal inhibitory concentration 
of 60 pgiml. At this concentration and above (up to 150 
~g~rnl~ no lysis of erythrocytes was observed. The spe- 
cific antibacterial activity of SLS can be rationalized in 
terms of differences in the interaction with the bacterial 
and red blood cell surfaces, as in the case of SPLN and 
SPF [ 131. The presence of two arginine residues and one 
lysine residue would favour binding of SLS to the nega- 
tively charged lipopolysaccharide molecules located on 
the exterior of the outer membrane of E. coli [33] and 
disrupt the structure, facilitating entry into the cytoplas- 
mic membrane. It is likely that SLS then permeabilizes 
the bacterial plasma membrane like SPLN and SPF. 
The peptide does not reach the lipid bilayer ofthe eryth- 
rocyte membrane, probably as a consequence of bind- 
ing to sialic acid residues which project out of the mem- 
brane surface. 
In order to confirm the membrane permeabiliziag 
ability of SLS, we examined its ability to cause release 
of CF from model membranes. The fluorescence of CF 
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Fig. 3. Release of entrapped carboxyfluorescein (CF) from DOPC 
vesicles m the presence of varymg concentrations of SLS. Lipid = 
100pM. The concentratron of peptrde ts mdmated on the traces. 
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Fig. 4. Cncular dichroism spectrum (CD) and helical wheel proJection of SLS. (A) CD spectrum m micelles of SDS (30 mM). peptide concentra- 
tton = 0.05 mg/ml. The spectrum was recorded in a Jobm Yvon dichrograph v spectropolartmeter at 25°C m cells of 1 mm path length. 0 values 
are mean residue ellipttcities. (B) Helical wheel projectton. 
is very weak when entrapped in lipid vesicles and en- 
hanced considerably on dilution [24]. Hence increase of 
CF fluorescence is a measure of vesicle permeabiliza- 
tion. The CF release profiles from DOPC vesicles in the 
presence of varying concentrations of SLS as a function 
of time is shown in Fig. 3. CF release is clearly discern- 
ible. Similar results were obtained with lipid vesicles 
composed of phosphatidylethanolamine and phosphati- 
dylglycerol which mimic the lipid composition of the 
bacterial inner membrane. It is evident that SLS, like 
SPLN and SPF, has the ability to form pores in model 
membranes. 
In order to determine whether SLS has the propensity 
to adopt a helical structure, its conformation in an hy- 
drophobic environment was examined by circular di- 
chroism (CD) spectroscopy. The CD spectrum shown 
in Fig. 4A indicates a tendency of the peptide to adopt 
a helical conformation. The low helical content (- 30%, 
estimated by the method of Taylor and Kaiser [25]) 
could arise due to the strong length dependence of the 
ellipticity values in peptides [26]. The axial projection of 
the helical conformation shown in Fig. 4B indicates the 
amphiphilic nature of the helix. 
Thus both the 13-residue segments of SPLN pre- 
dicted to be ‘surface seeking’ have antimicrobial activ- 
ity. While SLS is not hemolytic. SPF has hemolytic 
activity. The peptides have the ability to form pores in 
lipid vesicles. The peptides span the region between res- 
idues 14 and 40 in SPLN, and our contention that re- 
gions 1426 and 2940 span the lipid bilayer and are 
responsible for forming channels is supported by the 
membrane activity of SLS and SPF. Regions 1-13 and 
4147 in SPLN have a net positive change and could 
play a role in effectively disrupting the lipopolysac- 
charide structure in the outer membrane of E. coli. In 
fact the minimal inhibitory concentration of SPLN (30 
pglml) [ 141 is less than those of SLS and SPF (50 pg/ml). 
Antimicrobial peptides, like ceropins and magainins, 
adopt predominantly helical conformations, and this 
structural feature is important for biological activity 
[27]. Based on hydrophobic moment and hydrophobi- 
city analysis on a number of antimicrobial and hemo- 
lytic peptides, Eisenberg and Werson noted short pep- 
tide segments which would be strongly ‘surface active’ 
[21]. However, the membrane activity of these short 
peptides have not been examined. A similar analysis on 
SPLN reveals two segments that could be surface seek- 
ing. Our results indicate that 13-residue peptides corre- 
sponding to both the segments exhibit antimicrobial 
activity, indicating that the approach by Eisenberg and 
Werson is a useful method for identifying short mem- 
brane-active peptide segments. 
Thus, peptide composed of only 13-residues can 
adopt helical structures which are amphiphilic and also 
exhibit antimicrobial activity. Identifying short bioac- 
tive segments in long peptide toxins and antibacterial 
peptides would help not only in rationalizing their bio- 
logical activity in terms of structure but also help in 
generating short bioactive peptides that can be of possi- 
ble therapeutic use. 
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